|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
gptkb:Ranbaxy_Laboratories
|
|
gptkbp:ceo
|
gptkb:Dilip_Shanghvi
|
|
gptkbp:employees
|
over 30,000
|
|
gptkbp:founded
|
gptkb:1993
|
|
gptkbp:founder
|
gptkb:Dilip_Shanghvi
|
|
gptkbp:global_presence
|
gptkb:Yes
|
|
gptkbp:headquarters
|
gptkb:Mumbai
gptkb:Maharashtra
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sun Pharmaceutical Industries
|
|
gptkbp:market
|
Global
|
|
gptkbp:products
|
Generic drugs
Specialty pharmaceuticals
|
|
gptkbp:research_and_development
|
gptkb:Yes
|
|
gptkbp:research_areas
|
gptkb:diabetes
gptkb:Cardiology
gptkb:Ophthalmology
gptkb:Telehealth_Services
gptkb:Oncology
gptkb:Biosimilars
gptkb:psychology
Cell therapy
Gastroenterology
Gene therapy
Immunology
Pain management
Regenerative medicine
Transplantation
Urology
Women's health
Neurology
Infectious diseases
Pediatric care
Endocrinology
Hematology
Orthopedics
Preventive care
Vaccines
Dermatology
Metabolic disorders
Diagnostics
Chronic diseases
Health supplements
Biologics
Cardiovascular
Respiratory
Nutraceuticals
Men's health
Rare diseases
Geriatric care
Digital health
Acute diseases
|
|
gptkbp:revenue
|
$4.5 billion (2021)
|
|
gptkbp:stock_exchange
|
gptkb:BSE
NSE
|
|
gptkbp:subsidiary
|
gptkb:Sun_Pharma_Advanced_Research_Company
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
www.sunpharma.com
|
|
gptkbp:bfsParent
|
gptkb:Pfizer
|
|
gptkbp:bfsLayer
|
4
|